Point72 Hong Kong LTD Aldeyra Therapeutics, Inc. Transaction History

Point72 Hong Kong LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$3.25 - $5.17 $25,031 - $39,819	-7,702 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.5 - $9.63 $26,957 - $74,170	7,702 New	7,702 $31,000
Q3 2021 Nov 15, 2021	SELL	$7.94 - $11.31 $2,366 - $3,370	-298 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$10.44 - $14.85 $3,111 - $4,425	298 New	298 $3,000
Q1 2020 May 15, 2020	SELL	$1.62 - $6.4 $1,106 - $4,371	-683 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$4.73 - $7.98 $3,230 - $5,450	683 New	683 $4,000

116

36.4M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $298M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.